Pictet Asset Management (UK)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $130M | Sell |
1,554,221
-10,992
| -0.7% | -$917K | 0.14% | 194 |
|
|
2021
Q1 | $118M | Sell |
1,565,213
-335,455
| -18% | -$25.3M | 0.14% | 187 |
|
|
2020
Q4 | $167M | Buy |
1,900,668
+400
| +0% | +$35.1K | 0.22% | 135 |
|
|
2020
Q3 | $145M | Buy |
1,900,268
+104,347
| +6% | +$7.94M | 0.23% | 134 |
|
|
2020
Q2 | $222M | Buy |
1,795,921
+687,617
| +62% | +$84.8M | 0.38% | 74 |
|
|
2020
Q1 | $93.7M | Buy |
1,108,304
+348,443
| +46% | +$29.4M | 0.2% | 139 |
|
|
2019
Q4 | $64.2M | Buy |
759,861
+171,567
| +29% | +$14.5M | 0.11% | 221 |
|
|
2019
Q3 | $39.7M | Sell |
588,294
-765,047
| -57% | -$51.6M | 0.08% | 264 |
|
|
2019
Q2 | $116M | Sell |
1,353,341
-9,414
| -0.7% | -$806K | 0.25% | 121 |
|
|
2019
Q1 | $121M | Buy |
1,362,755
+59,728
| +5% | +$5.31M | 0.27% | 111 |
|
|
2018
Q4 | $111K | Buy |
1,303,027
+84,676
| +7% | +$7.21K | 0.28% | 112 |
|
|
2018
Q3 | $118M | Sell |
1,218,351
-222,670
| -15% | -$21.6M | 0.25% | 123 |
|
|
2018
Q2 | $136M | Sell |
1,441,021
-118,184
| -8% | -$11.1M | 0.32% | 90 |
|
|
2018
Q1 | $126M | Buy |
1,559,205
+253,787
| +19% | +$20.6M | 0.31% | 94 |
|
|
2017
Q4 | $116M | Buy |
1,305,418
+170,796
| +15% | +$15.2M | 0.3% | 97 |
|
|
2017
Q3 | $106M | Buy |
1,134,622
+164,788
| +17% | +$15.3M | 0.3% | 97 |
|
|
2017
Q2 | $85M | Sell |
969,834
-14,143
| -1% | -$1.24M | 0.26% | 117 |
|
|
2017
Q1 | $86.4M | Sell |
983,977
-15,228
| -2% | -$1.34M | 0.28% | 105 |
|
|
2016
Q4 | $82.8M | Buy |
999,205
+104,362
| +12% | +$8.65M | 0.31% | 92 |
|
|
2016
Q3 | $82.8M | Sell |
894,843
-73,452
| -8% | -$6.8M | 0.31% | 89 |
|
|
2016
Q2 | $86.8M | Buy |
968,295
+703,112
| +265% | +$63M | 0.34% | 80 |
|
|
2016
Q1 | $21.7M | Sell |
265,183
-31,041
| -10% | -$2.54M | 0.1% | 241 |
|
|
2015
Q4 | $31M | Buy |
296,224
+60,030
| +25% | +$6.29M | 0.13% | 205 |
|
|
2015
Q3 | $24.9M | Sell |
236,194
-92,903
| -28% | -$9.78M | 0.11% | 232 |
|
|
2015
Q2 | $48.1M | Buy |
329,097
+57,428
| +21% | +$8.4M | 0.2% | 138 |
|
|
2015
Q1 | $30.4M | Sell |
271,669
-69,167
| -20% | -$7.75M | 0.13% | 215 |
|
|
2014
Q4 | $30.8M | Buy |
340,836
+153,530
| +82% | +$13.9M | 0.14% | 191 |
|
|
2014
Q3 | $13.5M | Sell |
187,306
-15,400
| -8% | -$1.11M | 0.07% | 323 |
|
|
2014
Q2 | $12.6M | Buy |
202,706
+28,300
| +16% | +$1.76M | 0.06% | 336 |
|
|
2014
Q1 | $11.9M | Buy |
174,406
+14,400
| +9% | +$982K | 0.06% | 339 |
|
|
2013
Q4 | $11.2M | Sell |
160,006
-17,700
| -10% | -$1.24M | 0.06% | 331 |
|
|
2013
Q3 | $12.8M | Sell |
177,706
-57,300
| -24% | -$4.14M | 0.07% | 287 |
|
|
2013
Q2 | $13.1M | Buy |
+235,006
| New | +$13.1M | 0.08% | 262 |
|